The drugs, which also include Mounjaro and Zepbound (tirzepatide), as well as Victoza and Trulicity, all belong to a class of medications known as glucagon-like peptide 1 (GLP-1) receptor agonists
The pharmaceutical industry has developed drugs that mimic the GLP-1 targeting control of glucose levels in type-2 diabetes
How PlexusDx Supports a More Personalized Approach PlexusDx's Precision Peptide Genetic Test may help provide context regarding genetic variations affecting antioxidant and metabolic pathways
Zhang X, Selvaraju K, Saei AA, DArcy P, Zubarev RA, Arner ES, Linder S (2019) Repurposing of auranofin: Thioredoxin reductase remains a primary target of the drug
Diabetes Care (2010) 33(4):e588
a lower MARD indicates greater accuracy